{"nct_id":"NCT01961609","title":"Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.","status":"COMPLETED","status_verified_date":"2018-12","start_date":"2013-10-09","start_date_type":"ACTUAL","primary_completion_date":"2016-07-12","primary_completion_date_type":"ACTUAL","completion_date":"2016-07-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}